Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chompunoot Kongsawatvorakul, Chuenkamon Charakorn, Suwicha Chittithaworn & Arb-Aroon Lertkhachonsuk. (2022) Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer. Journal of Obstetrics and Gynaecology 42:6, pages 2331-2335.
Read now
Read now
Yunke Huang, Jing Xu, Ke Li, Jing Wang, Yilin Dai & Yu Kang. (2021) A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report. Cancer Management and Research 13, pages 2849-2867.
Read now
Read now
Andrew T Lucas, Andrew J Madden & William C Zamboni. (2015) Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1419-1433.
Read now
Read now
Roland Kontermann. (2012) Dual targeting strategies with bispecific antibodies. mAbs 4:2, pages 182-197.
Read now
Read now